Carnegie Mellon University
Browse

Patient-Funded Trials: Opportunity or Liability?

Download (42.55 kB)
journal contribution
posted on 2015-08-06, 00:00 authored by Danielle WennerDanielle Wenner, Jonathan Kimmelman, Alex LondonAlex London

Patient-funded trials (PFTs) are gaining traction as a means of accelerating clinical translation. However, such trials sidestep mechanisms that promote rigor, relevance, efficiency, and fairness. We recommend that funding bodies or research institutions establish mechanisms for merit review of patient-funded trials, and we offer some basic criteria for evaluating PFT protocols.

History

Publisher Statement

This is the author’s version of a work that was accepted for publication. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version is available at http://dx.doi.org/10.1016/j.stem.2015.07.016

Date

2015-08-06

Usage metrics

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC